BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2564 related articles for article (PubMed ID: 12094235)

  • 1. The phosphatidylinositol 3-Kinase AKT pathway in human cancer.
    Vivanco I; Sawyers CL
    Nat Rev Cancer; 2002 Jul; 2(7):489-501. PubMed ID: 12094235
    [No Abstract]   [Full Text] [Related]  

  • 2. The phosphoinositide 3-kinase pathway.
    Cantley LC
    Science; 2002 May; 296(5573):1655-7. PubMed ID: 12040186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
    Luo J; Manning BD; Cantley LC
    Cancer Cell; 2003 Oct; 4(4):257-62. PubMed ID: 14585353
    [No Abstract]   [Full Text] [Related]  

  • 4. Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
    Ott VL; Cambier JC
    Semin Immunol; 2002 Feb; 14(1):1-6. PubMed ID: 11884225
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
    Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
    J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
    Franke TF; Yang SI; Chan TO; Datta K; Kazlauskas A; Morrison DK; Kaplan DR; Tsichlis PN
    Cell; 1995 Jun; 81(5):727-36. PubMed ID: 7774014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKT and the phosphatidylinositol 3-kinase/AKT pathway: important molecular targets for lung cancer prevention and treatment.
    Crowell JA; Steele VE
    J Natl Cancer Inst; 2003 Feb; 95(4):252-3. PubMed ID: 12591974
    [No Abstract]   [Full Text] [Related]  

  • 9. The Akt-mTOR tango and its relevance to cancer.
    Hay N
    Cancer Cell; 2005 Sep; 8(3):179-83. PubMed ID: 16169463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatidylinositol 3-kinase: a key regulator of vascular tone?
    Sata M; Nagai R
    Circ Res; 2002 Aug; 91(4):273-5. PubMed ID: 12193457
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.
    Slupianek A; Nieborowska-Skorska M; Hoser G; Morrione A; Majewski M; Xue L; Morris SW; Wasik MA; Skorski T
    Cancer Res; 2001 Mar; 61(5):2194-9. PubMed ID: 11280786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the phosphatidylinositol-3'-kinase/protein kinase B-dependent antiapoptotic pathway plays an important role in the development of radioresistance of human glioma cells.
    Schlegel J; Durchschlag G; Piontek G; Grosu AL
    Ann N Y Acad Sci; 2002 Nov; 973():224-7. PubMed ID: 12485866
    [No Abstract]   [Full Text] [Related]  

  • 14. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
    Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
    Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription.
    Ghosh-Choudhury N; Abboud SL; Nishimura R; Celeste A; Mahimainathan L; Choudhury GG
    J Biol Chem; 2002 Sep; 277(36):33361-8. PubMed ID: 12084724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K-Akt pathway: its functions and alterations in human cancer.
    Osaki M; Oshimura M; Ito H
    Apoptosis; 2004 Nov; 9(6):667-76. PubMed ID: 15505410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines.
    Takeda A; Osaki M; Adachi K; Honjo S; Ito H
    Pancreas; 2004 Apr; 28(3):353-8. PubMed ID: 15084985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phosphatidylinositol 3-kinase/Akt signaling pathway modulates the endocrine differentiation of trophoblast cells.
    Kamei T; Jones SR; Chapman BM; MCGonigle KL; Dai G; Soares MJ
    Mol Endocrinol; 2002 Jul; 16(7):1469-81. PubMed ID: 12089343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells.
    Petiot A; Ogier-Denis E; Blommaart EF; Meijer AJ; Codogno P
    J Biol Chem; 2000 Jan; 275(2):992-8. PubMed ID: 10625637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.
    King WG; Mattaliano MD; Chan TO; Tsichlis PN; Brugge JS
    Mol Cell Biol; 1997 Aug; 17(8):4406-18. PubMed ID: 9234699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 129.